Cargando…

Safer opioid distribution in response to the COVID-19 pandemic

COVID-19 has turned the world upside down in a very short period of time. The impact of COVID-19 will disproportionately effect people who are least able to protect themselves and this will include people who use drugs. The arrival of the COVID-19 pandemic comes at time when North America is in the...

Descripción completa

Detalles Bibliográficos
Autor principal: Tyndall, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383133/
https://www.ncbi.nlm.nih.gov/pubmed/32739148
http://dx.doi.org/10.1016/j.drugpo.2020.102880
_version_ 1783563384700010496
author Tyndall, Mark
author_facet Tyndall, Mark
author_sort Tyndall, Mark
collection PubMed
description COVID-19 has turned the world upside down in a very short period of time. The impact of COVID-19 will disproportionately effect people who are least able to protect themselves and this will include people who use drugs. The arrival of the COVID-19 pandemic comes at time when North America is in the midst of a protracted overdose epidemic caused by a toxic illegal drug supply. Overdose deaths are likely to rise when people are isolated, social support programs are cut back, and the illicit drug supply is further compromised. Safer opioid distribution in response to a toxic street drug supply is a pragmatic and effective way to reduce overdose deaths. COVID-19 makes such an approach even more urgent and compelling.
format Online
Article
Text
id pubmed-7383133
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-73831332020-07-28 Safer opioid distribution in response to the COVID-19 pandemic Tyndall, Mark Int J Drug Policy Commentary COVID-19 has turned the world upside down in a very short period of time. The impact of COVID-19 will disproportionately effect people who are least able to protect themselves and this will include people who use drugs. The arrival of the COVID-19 pandemic comes at time when North America is in the midst of a protracted overdose epidemic caused by a toxic illegal drug supply. Overdose deaths are likely to rise when people are isolated, social support programs are cut back, and the illicit drug supply is further compromised. Safer opioid distribution in response to a toxic street drug supply is a pragmatic and effective way to reduce overdose deaths. COVID-19 makes such an approach even more urgent and compelling. Published by Elsevier B.V. 2020-09 2020-07-27 /pmc/articles/PMC7383133/ /pubmed/32739148 http://dx.doi.org/10.1016/j.drugpo.2020.102880 Text en © 2020 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Commentary
Tyndall, Mark
Safer opioid distribution in response to the COVID-19 pandemic
title Safer opioid distribution in response to the COVID-19 pandemic
title_full Safer opioid distribution in response to the COVID-19 pandemic
title_fullStr Safer opioid distribution in response to the COVID-19 pandemic
title_full_unstemmed Safer opioid distribution in response to the COVID-19 pandemic
title_short Safer opioid distribution in response to the COVID-19 pandemic
title_sort safer opioid distribution in response to the covid-19 pandemic
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383133/
https://www.ncbi.nlm.nih.gov/pubmed/32739148
http://dx.doi.org/10.1016/j.drugpo.2020.102880
work_keys_str_mv AT tyndallmark saferopioiddistributioninresponsetothecovid19pandemic